NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Zydus Lifesciences has entered into a Memorandum of Understanding with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection (MCD) test in India. This partnership utilizes Zydus's exclusive agreement with Guardant Health to provide a non-invasive, blood-based screening tool for 10 common cancer types.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
